-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Nurix Therapeutics, Raises Price Target to $30

Benzinga·12/09/2025 18:52:10
Listen to the news
BTIG analyst Jeet Mukherjee maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and raises the price target from $27 to $30.